| Treatment group | Structure (0 to 30)a | Tangential (0 to 6)a | Transitional (0 to 30)a | Safranin-O staining (0 to 12)a | Pannus (0 to 9)a | Total (0 to 87)a |
---|---|---|---|---|---|---|---|
Femoral condyles | Placebo | 20.50 ± 0.92 | 5.75 ± 0.19 | 15.63 ± 0.70 | 4.69 ± 0.33 | 0.88 ± 0.24 | 47.55 ± 1.74 |
 | ASU (10 mg/kg) | 11.44 ± 0.90 (P < 0.0001) | 3.81 ± 0.25 (P < 0.0001) | 12.88 ± 0.42 (P = 0.006) | 3.69 ± 0.24 (P = 0.03) | 0.19 ± 0.10 (P = 0.004) | 32.31 ± 1.64 (P < 0.0001) |
Tibial plateaus | Placebo | 20.69 ± 0.64 | 5.75 ± 0.14 | 16.88 ± 0.79 | 4.75 ± 0.40 | 1.75 ± 0.34 | 49.81 ± 1.86 |
 | ASU (10 mg/kg) | 13.25 ± 1.52 (P < 0.0001) | 4.19 ± 0.28 (P = 0.0002) | 13.06 ± 0.55 (P = 0.001) | 4.25 ± 0.31 | 1.62 ± 0.36 | 36.38 ± 2.07 (P = 0.0002) |